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Edited by Barry HalliwellAbstract The critical point at which apoptosis becomes irre-
versible and how cells attain an anti-apoptotic state remain
unknown. Here, we report that apoptotic cells undergoing
early-stage dynamic membrane blebbing revive. We examined
this phenomenon in cell lines that stably express 2DED2DD, a
modiﬁed FADD produced by fusing the tandem death eﬀector
domains (DEDs) and tandem death domains (DDs). Induction
of apoptosis caused rapid blebbing. Eight hours later, most cells
shrunk while some detached from the ﬂask. Twenty-four hours
later, when activated caspase 3 decreased, more than half the
cells revived and appeared normal, probably due to the induction
of unidentiﬁed anti-apoptotic proteins.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Whether a cell dies or lives depends on the balance of proa-
poptotic and anti-apoptotic factors within multiple and over-
lapping networks of cellular cascades. Malignant cells are
able to survive because they counteract various apoptotic pro-
teins through various means, including strong induction of
anti-apoptotic proteins, ampliﬁcation of anti-apoptotic genes,
deletion of apoptotic genes, and depression of apoptotic pro-
teins through epigenesis [1,2].
Fas/TNFRSF6-associated protein with death domain
(FADD) is an adaptor molecule that mediates apoptotic cell
signals by interacting with various cell surface receptors [3].
Through its C-terminal death domain (DD), FADD can be
recruited by diﬀerent tumor necrosis factor receptors (TNFRs)
such as Fas/TNFRSF6 receptor, TNFRSF25, and TNFSF10/
TRAIL receptor. The FADD N terminus contains a death
eﬀector domain (DED), which recruits caspase to the death-Abbreviations: FADD, Fas-associated death domain protein; DISC,
death-inducing signaling complex; cFLIP, cellular FADD-like inter-
leukin-1b converting enzyme-inhibitory protein; PBS, phosphate-
buﬀered saline
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doi:10.1016/j.febslet.2007.08.033inducing signaling complex (DISC) and initiates the apoptotic
caspase cascade [4]. Recruitment of caspase 8 to the receptors
results in oligomerization of the caspase 8 protein, which then
drives its autoactivation through self-cleavage. Finally, acti-
vated caspase 8 activates other downstream caspases.
Previously, we showed that modiﬁcation of FADD to
2DEDplusE by fusing its tandem DEDs to the E protein of
lambda phage, a head coat protein with self-assembly activity,
greatly increases the apoptosis-inducing activity of FADD in
both adherent NIH3T3 and HEK293 cells [5]. In that study,
we also showed that 2DED2DD protein, which is composed
of tandem DEDs and tandem DDs, displays intermediate
apoptosis-inducing activity. The apoptosis-inducing activity
of 2DED2DD is stronger than that of unmodiﬁed FADD
but weaker than that of the 2DEDplusE protein. Five hours
after induction, approximately 40% of cells were aﬀected and
had detached. Interestingly, approximately 24 h after induc-
tion of 2DED2DD expression, the number of adherent cells in-
creased again. It is possible that this increase was due to
reattachment of cells. An alternative but less likely possibility
is that this increase was due to proliferation of surviving cells.
In the present study, we analyzed in detail this phenomenon –
revival of apoptotic cells – because this phenomenon is an
excellent model for analyzing the mechanism underlying the
survival of malignant cells and of normal cells that adopt an
anti-apoptotic state through the balance of pro- and anti-
apoptotic proteins.2. Materials and methods
2.1. Live cell imaging by time-lapse microscopy
Cells were observed using phase contrast microscopy (Olympus
IX71, Tokyo, Japan) with an UplanFL N40·/0.75 Ph objective lens
and a CO2 incubator on a heated stage for microscopy (Olympus
MI-IBC-I, Japan). Images were recorded using a CCD camera (Ham-
amatsu ORCA-ER, Japan) and AQUA-C imaging software (Compix
Inc.). Typically, 5 · 104 cells were plated onto 35 mm, poly-D-lysine-
coated glass bottom dishes. Twenty-four hours after subculture, tetra-
cycline was added to the culture medium and the cells were recorded
continuously at 5 min intervals.
2.2. Immunoblot analysis
Cells were plated at a density of 2 · 105 cells per 35 mm dish with an
appropriate DMEM medium. Twenty-four hours after subculture, tet-
racycline was added. At the indicated times, both detached and at-
tached cells were pooled, and cell extracts were prepared by washing
the cells with phosphate-buﬀered saline (PBS) and adding 50 ll of
Chaps Cell Extract Buﬀer (Cell Signaling Technology, Inc.) or solubi-
lization buﬀer (25 mM Tris–HCl, pH 6.8; 2% SDS). The proteinblished by Elsevier B.V. All rights reserved.
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Forty micrograms of each extract were separated on 10% polyacryl-
amide gels and blotted onto nitrocellulose transfer membranes (PRO-
TRAN; Schleicher & Schuell, Dassel, Germany) using a semi-dry
system (ATTO Co., Tokyo, Japan). Membranes were blocked with
1% blocking reagent (Boehringer) in PBS containing 0.1% Tween-20,
then incubated with primary antibody solution prepared in 1% BSA/
0.1% Tween-20/PBS overnight at 4 C. We used the following primary
antibodies: mouse monoclonal anti-FADD antibody (1:1000) from
Stressgen Bioreagents Corp.; rabbit monoclonal anti-cleaved caspase
3 (Asp175) (5A1) (1:1000), rabbit polyclonal anti-Bcl2 (1:1000), anti-
cFLIP (1:1000), and anti-cIAP1 (1:1000) antibodies from Cell Signal-
ing Technology Inc.; and mouse monoclonal anti-actin (Ab-5) anti-
body (1:5000) from BD Biosciences. After incubation, membranes
were washed three times with PBS containing 0.1% Tween-20 and then
incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit
or anti-mouse IgG antibody (1:2000; Promega) in 1% blocking reagent
in PBS containing 0.1% Tween-20. After washing, immunoreactive
bands were detected using the ECL plus Western blotting detection
system (Amersham Biosciences) according to the manufacturer’s
instructions and visualized with a Luminescent Image Analyzer
LAS1000 (Fujiﬁlm).
2.3. Construction of plasmids expressing modiﬁed FADD-tagged
3·FLAG
The plasmid pTREx-2DED2DD allows production of a foreign
protein under the control of a tetracycline repressor system and
constitutively produces EGFP from a CMV promoter. pTREx-
2DED2DDFLAG was constructed by inserting a 3·FLAG sequence
into the C terminus of the 2DED2DD open reading frame. All con-
structs were conﬁrmed by DNA sequencing.
2.4. Fluorescence microscopy analysis
The cells were plated in appropriate medium on poly-D-lysine-
coated glass bottom dishes. Twenty-four hours after subculture, tetra-
cycline was added. At the indicated times, the cells were washed with
PBS, ﬁxed with 4% paraformaldehyde in 0.1 M phosphate buﬀer and
3.4% sucrose for 30 min at room temperature. The cells were then incu-
bated with blocking solution (10% goat serum, 1% BSA in PBS) for 1 h
at room temperature and incubated with primary antibodies (anti-
cleaved caspase 3 (Asp175) (5A1) or anti-FADD) in 1% BSA/PBS
overnight at 4 C. After washing, the cells were incubated with Cy3-Fig. 1. Serial images of apoptotic 2DED2DD-expressing cells that were rev
lysine-coated glass bottom dishes. One day after plating, tetracycline was add
were acquired by time-lapse microscopy at intervals of 60 min. A movie sho
Supplementary material. Scale bar: 10 lm.conjugated anti-rabbit or anti-mouse IgG antibodies (Amersham).
The cells were observed using an inverted microscope (Zeiss Axiovert
S100, Germany; lens Plan-NEOFLUAR 10·/0.30 and Plan-NEOFL-
UAR 40·/0.75) and recorded using a CCD camera (Olympus DP70,
Japan).3. Results and discussion
3.1. Apoptotic cells were revived
In our previous study, we reported that cells expressing
2DED2DD protein detached from glass dishes, but one day
after inducing 2DED2DD expression, the number of adherent
cells increased, perhaps due to cell reattachment or due to
other reasons ([5] and cf. Fig. 3A). In the present study, we
analyzed this phenomenon in detail to determine whether
apoptotic cells can be revived. We studied this phenomenon
in the stable cell line of HEK293 cells we used previously be-
cause this line allows us to induce 2DED2DD expression,
which is under the control of a tetracycline repressor system
[5]. As shown in Fig. 1, immediately after treating the cells with
tetracycline, the cells moved actively like normal cells. Some-
times we observed cells dividing. Five hours after inducing
2DED2DD expression, some cells shrunk and underwent
membrane blebbing. Hours (8–10) after induction, most cells
became spherical and some cells detached from the bottom
of the dish. Most cells shrunk and formed clustered small balls,
that is, exhibited blebbing.
From our time-lapse microscopy observations, we found
that cells expressing 2DED2DD have three fates. Firstly, some
cells initially showed signs of apoptosis then appeared normal.
Shortly after 2DED2DD induction, these cells shrunk and dis-
played membrane blebbing. Curiously, the blebbing disap-
peared then re-appeared repeatedly a couple of times.
Twenty-four hours after induction, the blebbing faded com-
pletely (Fig. 1, arrowhead), and the cells bound tightly to theived. A stable cell line expressing 2DED2DD was plated onto poly-D-
ed to the culture medium. Serial images of 2DED2DD-expressing cells
wing the movement of these cells at intervals of 5 min is available as
ig. 2. Time course of the induction of 2DED2DD expression and
ctivation of caspase 3. (A) Immunoblot analysis was performed using
xtracts of 2DED2DD-stably transfected cells 2, 4, 6, 8, 12, 24, and
8 h (lanes 2–8) after tetracycline induction. Extract from cells cultured
ithout tetracycline is shown in lane 1. Activated caspase 3 was
etected using anti-caspase 3 antibody and the ECL plus Western
lotting detection system. (B) The cells were treated with z-VAD-fmk,
c-DEVD-CHO, or z-IETD-fmk 2 h before the addition of tetracy-
line. Arrowheads point to a full-length form and two processed forms
N 
of 2DED2DD. The triangle indicates endogenous FADD. (C) C-
terminal 3 · FLAG-tagged 2DED2DD was produced in HEK293
cells. Immunoblot analysis was performed on extracts from these cells
8 h after induction with tetracycline. The immunoblots were probed
with either anti-FADD or anti-FLAG tag antibodies. (D) Schematic
diagram showing the domain organization of modiﬁed FADD,
2DED2DD protein, and its putative processed sites. DED and DD
represent death eﬀector domain and death domain, respectively.
Arrows point to the putative processed sites of 2DED2DD.








csurface of the dish and spread normally. Secondly, some cells
that displayed membrane blebbing detached from the dish
and died (Fig. 1, arrow). The death of these cells was con-
ﬁrmed by propidium iodide (PI) staining. Thirdly, some cells
initially showed very few signs of apoptosis then appeared nor-
mal. Upon 2DED2DD induction, these cells shrunk but did
not display membrane blebbing. Shortly thereafter the cells
spread like typical healthy cells and moved actively. Although
the fates of individual cells expressing 2DED2DD varied, over-
all most cells began to shrink between 8 h and 12 h after induc-
tion, underwent membrane blebbing, then spread normally as
they did 24 h before induction. No apoptotic cells were ob-
served in a control experiment performed under the same con-
ditions but without tetracycline (data not shown).
3.2. Membrane blebbing is reversible in cells expressing full
or processed 2DED2DD protein
To examine the time course of 2DED2DD protein expres-
sion after tetracycline induction relative to the reversal of
membrane blebbing, we analyzed by immunoblotting extracts
of 2DED2DD stably transfected cells at diﬀerent times after
tetracycline induction. Before adding tetracycline, we detected
two faint signals – a 59 kDa band and a 42 kDa band – due to
leakage of our expression system. After adding tetracycline, we
detected three bands – 59 kDa, 54 kDa, and 42 kDa – with
anti-FADD antibody, which recognizes DD of FADD. The
59 kDa band represented full-length 2DED2DD protein,
which was conﬁrmed by additional immunoblot analysis and
by analyzing products of an in vitro translation/transcription
system (data not shown). Intact FADD has a molecular weight
of 23 kDa and an apparent molecular weight of 28 kDa on
SDS–PAGE (Fig. 2, triangle) [6]. Proteins representing the
54 kDa and 42 kDa bands were processed in vivo, probably
during the apoptosis cascade. All three signals increased grad-
ually 2–24 h after induction. The overall expression of
2DED2DD was consistent with the progression of apoptosis.
Immunoblot analysis using antibodies against the active
form of caspase 3, antibodies that do not recognize procaspase
3, was performed on the same extracts described above. As
shown in Fig. 2B, peak signals representing the active form
of caspase 3 were detected 4–6 h after induction, at a time
slightly before cells begin to shrink.
To examine whether some caspases participate in processing
the 54 kDa and 42 kDa forms of 2DED2DD, we pre-treated
2DED2DD-expressing cells with caspase inhibitors before tet-
racycline induction. The ratio of the three bands were not af-
fected by z-VAD-fmk, which inhibits all known caspases;
Ac-DEVD-CHO, which speciﬁcally inhibits caspases 3 and 7;
and z-IETD-fmk, which speciﬁcally inhibits caspase 8 and
Granzyme B. Thus, another non-caspase proteinase appears
to be involved in the processing of 2DED2DD. However,
Fig. 3. Uniform activation of caspase 3 after induction of 2DED2DD protein. (A) The stable cell line expressing 2DED2DD was subcultured in
poly-D-lysine-coated glass bottom dishes. At the indicated times after tetracycline induction, the cells were ﬁxed with 4% paraformaldehyde and
immunostained with anti-caspase antibodies that recognize the processed, active form of caspase 3, followed by Cy3-labeled secondary antibodies.
The cells were observed using ﬂuorescence microscopy. (a–g) Low magniﬁcation phase contrast microscopy images. Scale bar: 100 lm. (h–n) High
magniﬁcation phase contrast microscopy images. (o–u) Fluorescence microscopy images of cells stained with anti-caspase 3/Cy3-labeled antibodies.
Scale bar: 25 lm. (B) Two hours after tetracycline induction, cells were ﬁxed then sequentially immunostained with anti-FADD antibodies and Cy3-
labeled secondary antibodies. Phase contrast (a–c) and ﬂuorescence (d–f) microscopy images of untreated cells (a–e) and tetracycline-treated cells (c,
f). Scale bar: 25 lm.
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pletely that caspase 8 or 10 processes 2DED2DD by means
of the physical binding of the two DEDs of caspase 8/10 to
the tandem DEDs of 2DED2DD. To analyze in detail the pro-
cessed sites of 2DED2DD, we fused a 3·FLAG tag to the C
terminus of 2DED2DD protein, transiently expressed the fu-
sion protein in HEK293 cells, and detected the protein by
immunoblotting with anti-FLAG antibodies. As expected, in
the cell extracts we detected three bands representing frag-
ments of FLAG-tagged 2DED2DD protein. These bands
corresponded to the 59 kDa, 54 kDa, and 42 kDa bands of
full-length and processed 2DED2DD we identiﬁed earlier with
anti-FADD antibodies, but these bands were 5 kDa larger
because of the 3·FLAG tag. These results clearly show that
the N-terminal DED domain of 2DED2DD was excised or
processed out. By comparing the apparent sizes of the bands
on SDS–PAGE with those of the products prepared from an
in vitro transcription/translation system (data not shown), weconcluded that the 54 kDa fragment was composed of two-
thirds of a DED, one complete DED, and two DDs, and the
42 kDa fragment was composed of almost one DED and
two DDs (Fig. 2D). Concerning the in vivo processing of ori-
ginal FADD, Zhang and Winito described diﬀerent types of
processed FADD: A proteolytically processed FADD, which
is present only in the Fas-associated complex, and phosphory-
lated and non-phosphorylated forms of original FADD [6].
The physiological functions of these processed forms of
FADD remain unknown.
Both z-VAD-fmk, which inhibits all known caspases, and z-
IETD-fmk, which speciﬁcally inhibits caspase 8, abolished the
apoptosis-inducing properties of 2DED2DD. Ac-DEVD-
CHO, which speciﬁcally inhibits caspases 3 and 7, partially
inhibited the apoptosis-inducing properties of 2DED2DD
such that only 10% of the cells exhibited apoptosis. These
observations strongly suggest that blocking caspase 8 activity
during the initial stages of 2DED2DD-mediated apoptosis
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pase 8 activation. Thus, 2DED2DD-mediated apoptosis
induction follows the standard caspase cascade.
3.3. Induction of 2DED2DD uniformly activated caspase 3
in all cells
Based on caspase-Glo 3/7 assay results, we previously
reported that caspase 3 becomes activated about 3 h after
inducing 2DED2DD expression with tetracycline [5], which
was conﬁrmed in the present study (Fig. 2A). To conﬁrm
whether caspase 3 was activated uniformly in all cells by induc-
ing 2DED2DD, we immunostained cells for the active form
of caspase 3 at diﬀerent times after tetracycline treatment
and examined the staining with ﬂuorescence microscopy
(Fig. 3A). All cells displayed uniform activated-caspase 3
immunoreactivity, with the most brilliant signals observed 4
and 8 h after induction. This observation indicates that the
three fates of cells we described above do not result from var-
iable activated-caspase 3 content in 2DED2DD-expressing
cells. The signals representing the active form of caspase 3 de-
creased gradually from 24 to 42 h after induction, nearly disap-
pearing 72 h after induction. Twenty-four or more hours after
induction, despite abundant 2DED2DD expression, the
amount of activated caspase 3 decreased uniformly in all cells,
with most of the cells taking on a normal appearance. The time
course of caspase 3 activity, as determined through a caspase 3
colorimetric assay (data not shown), corroborates our results
from Western blotting (Fig. 2A) and immunostaining experi-
ments using an antibody against the active form of caspase 3
(anti-cleaved caspase 3 antibody) (Fig. 3A) . The expression
of 2DED2DD in all cells after tetracycline induction was also
conﬁrmed by immunostaining with anti-FADD antibody
(Fig. 3B). These phenomena strongly suggest, as a means of
cellular defense, at certain levels 2DED2DD may trigger theFig. 4. cFLIP, IAP, and Bcl-2 do not contribute to the revival of
apoptotic cells and to the decrease of activated caspase 3 after
2DED2DD induction. Immunoblot analysis was performed using
extracts of 2DED2DD-stably transfected cells 2, 4, 6, 8, 12, 24, and
48 h after tetracycline induction. Extracts from cells cultured without
tetracycline are also shown. Extracts of parental HEK293, NIH3T3,
and HeLa cells were used for control experiments. We analyzed the
expression of potential anti-apoptotic proteins with anti-cFLIP, anti-
cIAP1, and anti-Bcl2 antibodies and the ECL plus Western blotting
detection system. The asterisk indicates a non-speciﬁcally immuno-
stained band, based on information provided by the antibody supplier.machinery responsible for decreasing activated caspase 3 be-
fore apoptosis becomes irreversible.
To further assess apoptotic blebbing, we stained tetracy-
cline-induced, detached 2DED2DD-expressing cells with
Annexin V, which detects the externalization of phosphatidyl-
serine from the inner face of the plasma membrane to the cell
surface, and counterstained the cells with DAPI, which detects
DNA chromatin condensation (data not shown). Annexin V
and DAPI staining indicated that at least two stages of apop-
totic blebbing exist. Most cells that displayed early-stage apop-
totic blebbing exhibited no or weak Annexin V staining and no
DNA chromatin condensation. However, cells that displayed
late-stage apoptotic blebbing strongly stained with Annexin
V and exhibited signiﬁcant DNA chromatin condensation.
We believe that the cells displaying early-stage apoptotic bleb-
bing are the only cells that can be revived.
To examine the cellular mechanisms of anti-apoptosis pro-
cesses, we determined whether representative anti-apoptotic
proteins, cellular FADD-like interleukin-1b converting en-
zyme-inhibitory protein (cFLIP), IAP, and Bcl2 [7,8], were in-
duced in our experimental system. As shown in the
immunoblots of Fig. 4, Bcl2 was not induced, and the amount
of cFLIP and IAP remained unchanged following the induc-
tion of 2DED2DD expression. These results indicate that an-
other protein or mechanism is responsible for reversing the
blebbing displayed by apoptotic cells.
It is noteworthy that, at least under the apoptotic conditions
of our cell systems, HEK293 cells were more resistant to apop-
tosis than NIH3T3 and HeLa cells. Nevertheless, the amount
of cFLIP, IAP, and Bcl2 proteins in HEK293 cells was almost
the same or relatively less than that in NIH3T3 and HeLa cells.
Thus, it is likely that another anti-apoptosis mechanism is
mainly at work in HEK293 cells. One potential mechanism
for decreasing the active form of caspase 3 is via the ubiqui-
tin-proteasome pathway. An alternative mechanism may occur
through an unknown anti-apoptotic protein induced by
2DED2DD.
The sequential events that occur during apoptosis are as
follows: caspase activation, cell shrinkage, dynamic membrane
blebbing, condensation of chromatin, and DNA fragmenta-
tion. Membrane blebbing is deeply related to nuclear constric-
tions leading to nuclear fragmentation [9]. Many reports
describe the biochemical players involved in membrane
blebbing, including the actin-myosin system, the Rho eﬀector
protein ROCK I, LIM-kinase 1, and prostate-derived sterile
20-like kinase 2 (PSK2) [10–12]. Apoptosis and apoptotic bleb-
bing, once initiated, were considered to be irreversible despite
removal of apoptotic stimuli, although Torgerson and McNi-
ven found that suprastimulation of pancreatic acinar cells
reversed blebbing [13]. In the present study, we showed that
the apoptotic membrane blebbing that occurs after caspase 3
activation is reversible. That is, apoptotic cells in the initial
stages of apoptosis as manifested by membrane blebbing can
be revived. The revival of apoptotic cells in our 2DED2DD
system can shed light on novel anti-apoptotic mechanisms, be-
cause this system employs an artiﬁcial recombinant protein
and lacks the various side eﬀects that accompany the use of
chemical inhibitors. Candidate apoptotic factors will be identi-
ﬁed by future proteome analyses.Acknowledgements: We are grateful to E. Suzuki and S. Minorikawa
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